Alzamend Neuro Inc.
1.15
0.02 (1.77%)
At close: Jan 15, 2025, 1:43 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -0.48 -3.48 -7.31 -188.35 -218.79 -163.25 -1.24K -247.66 -4.81K
PS Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio -1.85 17.01 6.80 486.90 1.17K 2.50K 496.53 -664.69 -3.15M
P/FCF Ratio -0.57 -5.8 -13.5 -361.39 -410.04 -759.47 -561.3 -274.44 -18.07K
P/OCF Ratio -0.58 -5.8 -13.72 -361.39 -410.04 -759.47 -561.3 -274.44 -18.07K
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -0.12 n/a n/a 0.17 0.00 0.00 n/a -1.01 -29.42
Quick Ratio 0.14 2.03 12.37 3.26 1.83 1.27 24.98 0.08 0.18
Current Ratio 0.14 2.03 12.37 3.24 1.83 1.27 24.98 0.08 0.18
Asset Turnover n/a n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -983.83 -1.93K -264.8 -31.18 n/a n/a n/a n/a n/a
Return on Equity (ROE) 3.83 -4.89 -0.93 -2.59 -5.35 -15.34 -0.4 2.68 655.25
Return on Assets (ROA) -15.75 -2.52 -0.85 -1.79 -2.42 -3.24 -0.39 -11.87 -2.27
Return on Capital (ROIC) 3.83 -4.88 -0.92 -2.46 -5.38 -15.81 -0.39 2.65 655.25
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a